Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.830
-0.060 (-2.08%)
At close: Nov 28, 2025, 1:00 PM EST
2.850
+0.020 (0.71%)
After-hours: Nov 28, 2025, 4:35 PM EST
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.59 million as of November 28, 2025. Its market cap has decreased by -27.62% in one year.
Market Cap
1.59M
Enterprise Value
4.89M
1-Year Change
-27.62%
Ranking
Category
Stock Price
$2.83
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $1.59M, a decrease of -98.93%. That is a compound annual growth rate of -62.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.59M | -50.73% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |